Please login to the form below

Not currently logged in
Email:
Password:

WHO and FIP sign joint initiative for TB

The World Health Organisation and the International Pharmaceutical Federation has signed a joint statement to strengthen the role of pharmacists in tuberculosis care and control

The World Health Organisation (WHO) and the International Pharmaceutical Federation (FIP) have signed a joint statement, clarifying the role of pharmacists in tuberculosis (TB) care and control.

The statement, signed at the Federation's 71st International Congress in Hyderabad, India, puts forward a series of measures to help detect TB; offer treatment support; and reduce the number of deaths from the disease.

These measures would be achieved by engaging the FIP's network of pharmacists and pharmaceutical scientists and motivating them to become fully involved in national TB care and control efforts.

The statement calls on TB programmes and pharmacy associations to use their potential to increase awareness, provide patient-centered treatment supervision and refer people to facilities, amongst other suggestions.

Despite TB being one of the world's biggest infectious killers, it can be treated and cured through a six month course of prescribed medicines.

5th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics